Drugs for Neglected Diseases initiative - DNDi
Duncan Nyakaya is an experienced human resources professional with a strong background in HR management and organizational development. Currently serving as the Regional Human Resources Manager at Drugs for Neglected Diseases initiative (DNDi) since July 2014, Duncan has successfully managed payroll, developed HR procedures, overseen staff development and performance management, and handled recruitment and policy formulation. Previously, Duncan held roles at Telkom Kenya as a Reward & Development Officer and at AIESEC in Kenya as Vice President of Talent Management, focusing on talent marketing and training. Duncan's earlier experience includes promoting web standards as a campus crew representative for Opera Software and conducting socioeconomic assessments during an internship at AMPATH. With a Master of Business Administration from the University of Nairobi and multiple qualifications in human resources and accounting, Duncan brings a comprehensive skill set to the HR field.
This person is not in any offices
Drugs for Neglected Diseases initiative - DNDi
2 followers
The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development organization. We discover, develop, and deliver treatments for neglected patients around the world. Our treatments are affordable and patient-friendly – and have already saved millions of lives. We are researching new treatments for people living with Chagas disease, sleeping sickness (human African trypanosomiasis), leishmaniasis, filarial infections, mycetoma, paediatric HIV, hepatitis C, and dengue. Together with our partners, we are working on over 40 projects, including more than 20 new chemical entities. We are also running over 20 clinical trials. When the medical humanitarian organization Médecins Sans Frontières (MSF) won the Nobel Peace Prize in 1999, they dedicated a portion of the award to addressing this fatal imbalance and exploring a new, alternative, not-for-profit model for developing drugs for neglected patients. As a result in 2003, MSF, the World Health Organization, and five international research institutions founded DNDi.